Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
C3017 Guvacoline (hydrobromide)Summary: full agonist of atrial and ileal muscarinic receptors
-
C3869 BQCATarget: AChRSummary: positive allosteric modulator of the M1 muscarinic acetylcholine receptor (mAChR)
-
C4093 N-IsopropylnoratropineSummary: used in the synthesis of ipratropium, a muscarinic antagonist
-
C4635 Aceclidine (hydrochloride)Summary: agonist of muscarinic receptors
-
B5579 VU 0365114Summary: positive allosteric modulator of M5
-
B5632 PTAC oxalateSummary: muscarinic receptor ligand
-
B6317 4-DAMPSummary: A M3 cholinergic receptor antagonist
-
B6363 5-MethylfurmethiodideSummary: muscarinic agonist
-
B6471 Oxotremorine sesquifumarateSummary: Muscarinic agonist
-
B6579 Oxotremorine MSummary: Muscarinic receptor agonist